Conversion of Provisional Measure 1.791 of 1998
Defines the National Health Surveillance System, creates the National Health Surveillance Agency, and provides for other measures.
I hereby announce that the PRESIDENT OF THE REPUBLIC adopted Provisional Measure 1.791 of 1998, which the National Congress approved, and I, Antonio Carlos Magalhães, President, for the purposes of the sole paragraph of Art. 62 of the Federal Constitution, promulgate the following Law:
CHAPTER I
Art. 1 The National Health Surveillance System comprises the set of actions defined by § 1 of Art. 6 and by Arts. 15 to 18 of Law 8.080 of September 19, 1990, carried out by institutions of the direct and indirect Public Administration of the Union, the States, the Federal District, and the Municipalities that perform regulatory, standard-setting, control, and inspection activities in the area of health surveillance.
Art. 2 Within the National Health Surveillance System, the Union has jurisdiction to:
I - define the national health surveillance policy;
II - define the National Health Surveillance System;
III - regulate, control, and inspect products, substances, and services of interest to health;
IV - exercise health surveillance over ports, airports, and borders, and this duty may be exercised supplementarily by the States, the Federal District, and the Municipalities;
V - monitor and coordinate the health surveillance actions of the States, the Federal District, and the Municipalities;
VI - provide technical and financial cooperation to the States, the Federal District, and the Municipalities;
VII - act in special circumstances involving health risk; and
VIII - maintain a health surveillance information system, in cooperation with the States, the Federal District, and the Municipalities.
§ 1 The jurisdiction of the Union shall be exercised:
I - by the Ministry of Health, with regard to the formulation, monitoring, and evaluation of the national health surveillance policy and of the general guidelines of the National Health Surveillance System;
II - by the National Health Surveillance Agency - ANVS, in accordance with the duties conferred upon it by this Law; and
III - by the other bodies and entities of the Federal Executive Branch whose areas of activity relate to the system.
§ 2 The Federal Executive Branch shall define the allocation, among its bodies and entities, of the other duties and activities carried out by the National Health Surveillance System that are not covered by this Law.
§ 3 The States, the Federal District, and the Municipalities shall provide, by agreement, the information requested by the coordination of the National Health Surveillance System.
CHAPTER II — CREATION AND JURISDICTION OF THE NATIONAL
HEALTH SURVEILLANCE AGENCY
Art. 3 The National Health Surveillance Agency is hereby created as an autarchy under a special regime, linked to the Ministry of Health, with its seat and venue in the Federal District, for an indefinite term, and operating throughout the national territory.
Art. 3 The National Health Surveillance Agency - ANVISA is hereby created as an autarchy under a special regime, linked to the Ministry of Health, with its seat and venue in the Federal District, for an indefinite term, and operating throughout the national territory. (Wording given by Provisional Measure 2.039-24 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
Sole paragraph. The nature of special autarchy conferred upon the Agency is characterized by administrative independence, stability of its directors, and financial autonomy.
Art. 4 The Agency shall act as an independent administrative entity, and, under the terms of this Law, it is assured the prerogatives necessary for the proper exercise of its duties.
Art. 5 The Executive Branch shall install the Agency, and its regulation, approved by decree of the President of the Republic, shall establish its organizational structure.
Sole paragraph. The issuance of the regulation shall mark the installation of the Agency, automatically vesting it with the exercise of its duties. (Repealed by Provisional Measure 2.190-34 of 2001)
Art. 6 The institutional purpose of the Agency is to promote the protection of the health of the population by means of health control of the production and marketing of products and services subject to health surveillance, including the environments, processes, inputs, and technologies related to them, as well as the control of ports, airports, and borders.
Art. 7 The Agency has jurisdiction to implement and carry out the provisions of items II to VII of Art. 2 of this Law, and shall:
I - coordinate the National Health Surveillance System;
II - foster and conduct studies and research within the scope of its duties;
III - establish standards, and propose, monitor, and carry out health surveillance policies, guidelines, and actions;
IV - establish standards and norms on limits for contaminants, toxic residues, disinfectants, heavy metals, and others that involve a health risk;
V - intervene temporarily in the administration of producing entities that are financed, subsidized, or maintained with public funds, as well as in service providers and/or exclusive or strategic producers for supplying the national market, in compliance with Art. 5 of Law 6.437 of August 20, 1977, as worded by Art. 2 of Law 9.695 of August 20, 1998;
VI - administer and collect the health surveillance inspection fee instituted by Art. 23 of this Law;
VII - authorize the operation of companies that manufacture, distribute, and import the products mentioned in Art. 6 of this Law;
VII - authorize the operation of companies that manufacture, distribute, and import the products mentioned in Art. 8 of this Law and that market medicines; (Wording given by Provisional Measure 2.190-34 of 2001)
VIII - consent to the import and export of the products mentioned in Art. 8 of this Law;
IX - grant product registrations, according to the standards of its area of activity;
X - grant and cancel the certificate of compliance with good manufacturing practices;
XI - require, through specific regulation, conformity certification within the Brazilian Certification System - SBC, for products and services under the health surveillance regime according to their risk class; (Repealed by Provisional Measure 2.190-34 of 2001)
XII - require accreditation, within SINMETRO, of diagnostic and therapeutic support service laboratories and others of interest for controlling health risks to the population, as well as those that involve the incorporation of new technologies; (Repealed by Provisional Measure 2.190-34 of 2001)
XIII - require accreditation of public fiscal analysis laboratories within SINMETRO; (Repealed by Provisional Measure 2.190-34 of 2001)
XIV - interdict, as a health surveillance measure, the places of manufacture, control, import, storage, distribution, and sale of products and of provision of health-related services, in case of violation of the pertinent legislation or imminent health risk;
XV - prohibit the manufacture, import, storage, distribution, and marketing of products and inputs, in case of violation of the pertinent legislation or imminent health risk;
XVI - cancel the operating authorization and the special operating authorization of companies, in case of violation of the pertinent legislation or imminent health risk;
XVII - coordinate the health surveillance actions carried out by all laboratories that make up the official network of health quality control laboratories;
XVIII - establish, coordinate, and monitor the toxicological and pharmacological surveillance systems;
XIX - promote the periodic review and updating of the pharmacopoeia;
XX - maintain a continuous and permanent information system to integrate its activities with other health actions, giving priority to epidemiological surveillance actions and outpatient and hospital care;
XXI - monitor and audit the state, district, and municipal bodies and entities that are part of the National Health Surveillance System, including the official health quality control laboratories;
XXII - coordinate and carry out quality control of the goods and products listed in Art. 8 of this Law, by means of the analyses provided for in the health legislation or of special health quality monitoring programs;
XXIII - foster the development of human resources for the system and national and international technical-scientific cooperation;
XXIV - issue notices of violation and impose the penalties provided for by law.
XXV - monitor price trends for medicines, equipment, components, inputs, and health services, and for this purpose it may: (Added by Provisional Measure 2.190-34 of 2001)
a) require, when it deems necessary, information on production, inputs, raw materials, sales, and any other data held by persons governed by public or private law engaged in the production, distribution, and marketing of the goods and services provided for in this item, maintaining legal confidentiality where applicable; (See Provisional Measure 1.912-9 of 1999) (Added by Provisional Measure 2.190-34 of 2001)
b) examine the inventories, papers, and books of any companies or persons governed by public or private law engaged in the production, distribution, and marketing of the goods and services provided for in this item, maintaining legal confidentiality where applicable; (See Provisional Measure 1.912-9 of 1999) (Added by Provisional Measure 2.190-34 of 2001)
c) when evidence is found of infractions provided for in items III or IV of Art. 20 of Law 8.884 of June 11, 1994, through unjustified price increases or imposition of excessive prices for the goods and services referred to in those items, summon the responsible parties to justify their conduct within a maximum period of ten business days; (See Provisional Measure 1.912-9 of 1999) (Added by Provisional Measure 2.190-34 of 2001)
d) impose the penalty provided for in Art. 26 of Law 8.884 of 1994; (See Provisional Measure 1.912-9 of 1999) (Added by Provisional Measure 2.190-34 of 2001)
XXVI - control, inspect, and monitor, from the standpoint of the health legislation, the advertising and publicity of products subject to the health surveillance regime; (See Provisional Measure 2.000-17 of 2000) (Added by Provisional Measure 2.190-34 of 2001)
XXVII - define, by its own act, the places of entry and exit of narcotics, psychotropic substances, and precursors in the Country, after consulting the Federal Police Department and the Federal Revenue Secretariat. (See Provisional Measure 2.134-31 of 2001) (Added by Provisional Measure 2.190-34 of 2001)
XXVIII - inspect the formation, by public and private health establishments, whether or not affiliated with the Unified Health System - SUS, of the Registry, Surveillance, and Monitoring Committees for At-Risk Pregnant and Postpartum Women within the National System for Registry, Surveillance, and Monitoring of Pregnant and Postpartum Women for the Prevention of Maternal Mortality. No effect (Added by Provisional Measure 557 of 2011)
§ 1 The Agency may delegate to the States, the Federal District, and the Municipalities the performance of duties that are its own, except for those provided for in items I, V, VIII, IX, XV, XVI, XVII, XVIII, and XIX of this Article.
§ 2 The Agency may advise, complement, or supplement the actions of the States, the Municipalities, and the Federal District for the exercise of health control.
§ 3 Epidemiological surveillance and vector control activities relating to ports, airports, and borders shall be carried out by the Agency, under the technical and normative guidance of the Ministry of Health.
§ 4o The Agency may delegate to a body of the Ministry of Health the performance of the duties provided for in this article that relate to medical, outpatient, and hospital services, as provided for in §§ 2o and 3o of art. 8o, subject to the prohibitions defined in § 1o of this article. (Added by Provisional Measure 2.190-34 of 2001)
§ 5o The Agency shall always base its actions on the guidelines established by Law 8.080 of September 19, 1990, in order to continue the process of decentralizing the performance of activities to the States, the Federal District, and the Municipalities, subject to the prohibitions listed in § 1o of this article. (Added by Provisional Measure 2.190-34 of 2001)
§ 6o The decentralization referred to in § 5o shall be carried out only after a favorable opinion from the respective State, District, and Municipal Health Councils. (Added by Provisional Measure 2.190-34 of 2001)
§ 7o To comply with item X of this article, the Agency may use confidential information on inspections received under agreements or conventions with the sanitary authorities of other countries, and may authorize inspections and surveys at manufacturing plants by national or international institutions accredited by the Agency for such activities. (Added by Law 13.097 of 2015)
Art. 8º The Agency is responsible for regulating, controlling, and inspecting, in compliance with the legislation in force, products and services that involve risk to public health.
§ 1º The following goods and products are considered subject to sanitary control and inspection by the Agency:
I - medicines for human use, their active substances and other inputs, processes, and technologies;
II - foods, including beverages, bottled waters, their inputs, their packaging, food additives, limits of organic contaminants, and residues of pesticides and veterinary medicines;
III - cosmetics, personal hygiene products, and perfumes;
IV - sanitizing products intended for cleaning, disinfection, or disinfestation in household, hospital, and collective environments;
V - kits, reagents, and inputs intended for diagnosis;
VI - medical-hospital, dental, and hemotherapy equipment and materials, and laboratory and imaging diagnostic equipment and materials;
VII - immunobiologicals and their active substances, blood, and blood derivatives;
VIII - human and veterinary organs and tissues for use in transplants or reconstitutions;
IX - radioisotopes for in vivo diagnostic use, and radiopharmaceuticals and radioactive products used in diagnosis and therapy;
X - cigarettes, cigarillos, cigars, and any other smoking product, whether or not derived from tobacco;
XI - any products that involve the possibility of health risk, obtained by genetic engineering or another procedure, or that are subjected to radiation sources.
§ 2º The following services are considered subject to sanitary control and inspection by the Agency: those directed to outpatient care, whether routine or emergency; those performed on an inpatient basis; diagnostic and therapeutic support services; and those that entail the incorporation of new technologies.
§ 3º Without prejudice to the provisions of §§ 1º and 2º of this article, the physical facilities, equipment, technologies, environments, and procedures involved in all phases of the production processes of the goods and products subject to sanitary control and inspection, including the disposal of their respective waste, are subject to the sanitary surveillance regime.
§ 4º The Agency may regulate other products and services of interest for the control of risks to the health of the population, covered by the National Sanitary Surveillance System.
§ 5o The Agency may exempt from registration immunobiologicals, insecticides, medicines, and other strategic inputs when acquired through international multilateral organizations, for use in public health programs by the Ministry of Health and its affiliated entities. (Added by Provisional Measure 2.190-34 of 2001)
§ 6o The Minister of State for Health may order the performance of actions within the authority of the Agência Nacional de Vigilância Sanitária, in specific cases that entail risk to the health of the population. (Added by Provisional Measure 2.190-34 of 2001)
§ 7o The act referred to in § 6o shall be published in the Diário Oficial da União. (Added by Provisional Measure 2.190-34 of 2001)
§ 8º Services and facilities related to the activities of ports, airports, and borders, and to customs stations and bonded terminals, and water, land, and air transport services, are considered subject to sanitary control and inspection. (See Provisional Measure 2.134-31 of 2001) (Added by Provisional Measure 2.190-34 of 2001)
Art. 8º-A. Failure by private health service providers to comply with the quality standards and qualification attributes that are part of the National Strategy for Quality Control and Assessment of Health Care Provided by the Private Sector constitutes an infraction punishable by a daily fine of R$ 5.000,00 (five thousand reais), which may be increased up to 100 (one hundred) times, if necessary to ensure its effectiveness, in light of the economic situation of the service provider. (Added by Law 15.524 of 2026)
Sole paragraph. The penalty referred to in the caput of this article applies without prejudice to: (Added by Law 15.524 of 2026)
I – civil liability in case of harm to the health of patients; (Added by Law 15.524 of 2026)
II – liability in case of concurrent noncompliance with consumer protection rules and rules issued by the Agência Nacional de Saúde Suplementar (ANS). (Added by Law 15.524 of 2026)
CHAPTER III — ORGANIZATIONAL STRUCTURE OF THE AUTARCHY
Section I — Basic Structure
Art. 9º The Agency shall be directed by a Collegiate Board, and shall also have an Attorney, an Inspector General, and an Ombudsman, in addition to specialized units charged with different functions.
Sole paragraph. The Agency shall also have an Advisory Council, as provided by regulation.
Sole paragraph. The Agency shall also have an Advisory Council, which shall include, at a minimum, representatives of the Union, the States, the Federal District, the Municipalities, producers, merchants, the scientific community, and users, as provided by regulation. (Wording given by Provisional Measure 2.190-34 of 2001)
Section II — The Collegiate Board
Art. 10. The management and administration of the Agency shall be exercised by a Collegiate Board, composed of up to five members, one of whom is its Director-President.
Sole paragraph. The Directors shall be Brazilian citizens, nominated and appointed by the President of the Republic after prior approval by the Federal Senate under art. 52, III, "f", of the Federal Constitution, to serve a term of three years, with a single reappointment permitted.
Art. 10. The management and administration of the Agency shall be exercised by a Collegiate Board composed of 5 (five) members, one of whom is its Director-President, with reappointment prohibited, pursuant to Law 9.986 of July 18, 2000. (Wording given by Law 13.848 of 2019) Effective Date
Sole paragraph. The members of the Collegiate Board shall be Brazilian citizens, nominated by the President of the Republic and appointed by him or her, after prior approval by the Federal Senate, pursuant to subitem “f” of item III of art. 52 of the Federal Constitution, to serve a term of 5 (five) years, subject to the provisions of Law 9.986 of July 18, 2000. (Wording given by Law 13.848 of 2019) Effective Date
Art. 11. The Director-President of the Agency shall be appointed by the President of the Republic from among the members of the Collegiate Board, and invested in the function for three years, or for the remainder of his or her term, with a single reappointment of three years permitted.
Art. 11. The Director-President of the Agency shall be appointed by the President of the Republic and invested in the function for 5 (five) years, with reappointment prohibited, subject to the provisions of Law 9.986 of July 18, 2000. (Wording given by Law 13.848 of 2019) Effective Date
Art. 12. The dismissal without cause of a Director of the Agency may be carried out only during the first four months of the term, after which full and complete exercise of the office shall be ensured, except in cases of an act of administrative misconduct, a final and unappealable criminal conviction, or unjustified noncompliance with the management contract of the autarchy. (Repealed by Law 13.848 of 2019) Effective Date
Art. 13. The directors of the Agency are prohibited from engaging in any other professional, business, or labor union activity, or in political-party leadership.
§ 1º The directors are likewise prohibited from having a direct or indirect interest in any company related to the area of activity of Sanitary Surveillance provided for in this Law, as provided by regulation.
§ 2º The prohibition referred to in the caput of this article does not apply to cases in which the professional activity arises from a contractual relationship maintained with public entities dedicated to teaching and research, including private-law entities linked to them.
§ 3º In case of noncompliance with the obligation provided for in the caput and in § 1o of this article, the violator shall lose his or her office, without prejudice to liability in the applicable civil and criminal actions.
Art. 14. Until one year after leaving office, a former director is prohibited from representing any person or interest before the Agency.
Sole paragraph. During the period established in the caput, a former director is also prohibited from using, for his or her own benefit, privileged information obtained by reason of the office held, under penalty of incurring an act of administrative misconduct.
Art. 15. The Collegiate Board has the authority to:
Art. 15. The Collegiate Board has the authority to: (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
I - exercise the administration of the Agency;
I - define the strategic guidelines of the Agency; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
II - propose to the Minister of State for Health the governmental policies and guidelines intended to enable the Agency to fulfill its objectives;
II - propose to the Minister of State for Health the governmental policies and guidelines intended to enable the Agency to fulfill its objectives; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
III - issue rules on matters within the authority of the Agency;
III - issue rules on matters within the authority of the Agency; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
III - issue rules on matters within the authority of the Agency, which must be accompanied by technical justifications and, whenever possible, by studies of the economic and technical impact on the regulated sector and of the impact on public health, this requirement being waived in cases of serious risk to public health; (Wording given by Law 13.411 of 2017) (Effective Date)
IV - approve the internal rules and define the area of activity, organization, and structure of each Directorate;
IV - comply with and enforce the rules on sanitary surveillance; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
V - comply with and enforce the rules on sanitary surveillance;
V - prepare and publish periodic reports on its activities; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
VI - prepare and publish periodic reports on its activities;
VI - adjudicate, on appeal, decisions of the Agency, upon petition of interested parties; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
VII - adjudicate, on appeal, decisions of the Board, upon petition of interested parties;
VII - forward the accounting statements of the Agency to the competent bodies. (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
VIII - forwarding the Agency's accounting statements to the competent bodies.
VIII - drafting, approving, and promulgating the internal rules, defining the area of operation of the organizational units and the executive structure of the Agency. (Added by Law 13.097 of 2015)
§ 1 The Board of Directors shall meet with at least four directors present, among them the Director-President or his or her legal substitute, and shall decide with at least three favorable votes.
§ 1 The Board of Directors shall meet with at least three Directors present, among them the Director-President or his or her legal substitute, and shall decide by simple majority. (Wording given by Provisional Measure 2.190-34 of 2001)
§ 1 The Board of Directors shall meet with at least 3 (three) Directors present, among them the Director-President or his or her legal substitute, and shall decide by absolute majority. (Wording given by Law 13.848 of 2019) Effectiveness
§ 2 An appeal from acts performed by the Agency may be filed with the Collegiate Board, with suspensive effect, as the last administrative instance.
§ 2 An appeal from acts performed by the Agency may be filed with the Collegiate Board, with suspensive effect, as the last administrative instance. (Wording given by Provisional Measure 2.190-34 of 2001)
§ 3 Unless otherwise provided, the deadline for filing the administrative appeal provided for in § 2 shall be thirty days, counted from the official publication of the decision under appeal. (Added by Law 13.411 of 2017) (Effectiveness)
§ 4 The final decision on the administrative appeal must be published within a maximum of ninety days, counted from the date the appeal was filed. (Added by Law 13.411 of 2017) (Effectiveness)
§ 5 The period provided for in § 4 may be extended for an equal period, upon publication of the corresponding justification. (Added by Law 13.411 of 2017) (Effectiveness)
§ 6 Failure to comply with the deadlines established in §§ 4 and 5 shall result in an investigation of the functional liability of the person or persons responsible in each of the specialized areas in charge of analyzing the case. (Added by Law 13.411 of 2017) (Effectiveness)
Art. 16. The Director-President is responsible for:
I - representing the Agency in court or out of court;
II - presiding over the meetings of the Collegiate Board;
III - complying with and enforcing the decisions of the Collegiate Board;
IV - deciding urgent matters ad referendum of the Collegiate Board;
V - casting the deciding vote in the event of a tie in the deliberations of the Collegiate Board;
VI - appointing and dismissing public servants, filling permanent positions, commissioned positions, and positions of trust, and exercising disciplinary authority, under the terms of the legislation in force;
VII - forwarding to the Advisory Council the periodic reports prepared by the Collegiate Board;
VIII - signing contracts and agreements and authorizing expenditures.
Art. 16. The Director-President is responsible for: (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
I - representing the Agency in court or out of court; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
II - presiding over the meetings of the Collegiate Board; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
III - deciding urgent matters ad referendum of the Collegiate Board; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
IV - casting the deciding vote in the event of a tie in the deliberations of the Collegiate Board; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
V - appointing and dismissing public servants, filling permanent positions, commissioned positions, and positions of trust, and exercising disciplinary authority, under the terms of the legislation in force; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
VI - forwarding to the Advisory Council the periodic reports prepared by the Collegiate Board; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
VII - signing contracts and agreements and authorizing expenditures; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
VIII - drafting, approving, and promulgating the internal rules, defining the area of operation of the organizational units and the executive structure of the Agency; (See Provisional Measure 2.000-16 of 2000) (Wording given by Provisional Measure 2.190-34 of 2001)
IX - exercising the operational management of the Agency. (See Provisional Measure 2.000-16 of 2000) (Added by Provisional Measure 2.190-34 of 2001)
Section III — Commissioned Positions and Commissioned Functions
Art. 17. The Commissioned Positions of Special Nature and of the Senior Management and Advisory Group - DAS are hereby created to form part of the structure of the Agency, as listed in Annex I to this Law.
Sole paragraph. The Commissioned Positions of the Senior Management and Advisory Group shall preferably be held by members of the personnel of the autarchy.
Art. 18. The positions of trust called Health Surveillance Commissioned Functions - FCVS are hereby created, to be exercised exclusively by public servants, in the number and amounts provided in Annex I to this Law. (Repealed by Law 9.986 of 2000)
§ 1 A servant appointed to an FCVS shall receive the pay of the permanent position, plus the value of the function to which the servant has been designated. (Repealed by Law 9.986 of 2000)
§ 2 The Collegiate Board of the Agency has the authority to provide for the reallocation of the numbers and the distribution of the FCVS within its organizational structure, in compliance with the hierarchical levels, the corresponding compensation amounts, and the respective total cost established in Annex I. (Repealed by Law 9.986 of 2000)
§ 3 Designation to a health surveillance commissioned function may not be combined with designation or appointment to any other form of commissioning, and its payment ceases during periods of the servant's leave, including those considered effective service, except for the periods referred to in items I, IV, VI, and VIII of Art. 102 of Law 8.112 of December 11, 1990, as amended by Law 9.527 of December 10, 1997. (Repealed by Law 9.986 of 2000)
CHAPTER IV — Management Contract
Art. 19. The administration of the Agency shall be governed by a management contract, negotiated between its Director-President and the Minister of State for Health, after prior consultation with the Ministers of State for Finance and for Budget and Management, within a maximum of ninety days following the appointment of the Director-President of the autarchy.
Art. 19. The Administration of the Agency shall be governed by a management contract, negotiated between its Director-President and the Minister of State for Health, after prior consultation with the Ministers of State for Finance and for Planning, Budget, and Management, within a maximum of one hundred and twenty days following the appointment of the Director-President of the autarchy. (See Provisional Measure 1.912-6 of 1999) (Wording given by Provisional Measure 2.190-34 of 2001) (Repealed by Law 13.848 of 2019) Effectiveness
Sole paragraph. The management contract is the instrument for evaluating the administrative performance of the autarchy and its results, establishing the parameters for the internal administration of the autarchy as well as the indicators that allow its periodic evaluation to be objectively quantified.
Sole paragraph. The management contract is the instrument for evaluating the administrative performance of Anvisa and its results, which establishes the parameters for the internal administration of the autarchy as well as the indicators that allow its periodic evaluation to be objectively quantified, and which must specify, at a minimum: (Wording given by Law 13.411 of 2017) (Effectiveness) (Repealed by Law 13.848 of 2019) Effectiveness
I - goals and deadlines for administrative, operational, and inspection performance; (Added by Law 13.411 of 2017) (Effectiveness) (Repealed by Law 13.848 of 2019) Effectiveness
II - budget forecast and schedule of financial disbursement of the funds necessary to meet the agreed goals; (Added by Law 13.411 of 2017) (Effectiveness) (Repealed by Law 13.848 of 2019) Effectiveness
III - obligations and responsibilities of the parties in relation to the agreed goals; (Added by Law 13.411 of 2017) (Effectiveness) (Repealed by Law 13.848 of 2019) Effectiveness
IV - system for monitoring and evaluation; (Added by Law 13.411 of 2017) (Effectiveness) (Repealed by Law 13.848 of 2019) Effectiveness
V - measures to be adopted in the event of unjustified noncompliance with the agreed goals and obligations; (Added by Law 13.411 of 2017) (Effectiveness) (Repealed by Law 13.848 of 2019) Effectiveness
VI - term of validity; (Added by Law 13.411 of 2017) (Effectiveness) (Repealed by Law 13.848 of 2019) Effectiveness
VII - requirements and conditions for revision of the management contract. (Added by Law 13.411 of 2017) (Effectiveness) (Repealed by Law 13.848 of 2019) Effectiveness
Art. 20. Unjustified noncompliance with the management contract shall result in the dismissal of the Director-President by the President of the Republic, upon request of the Minister of State for Health.
Art. 20. Unjustified noncompliance with the goals and obligations agreed upon in the management contract in two consecutive fiscal years shall result in the dismissal of the members of the Collegiate Board by the President of the Republic, upon request of the Minister of State for Health. (Wording given by Law 13.411 of 2017) (Effectiveness) (Repealed by Law 13.848 of 2019) Effectiveness
CHAPTER V — Assets and Revenues
Section I — Revenues of the Autarchy
Art. 21. The assets of the Agency consist of the property and rights it owns, those conferred on it, and those it acquires or incorporates.
Art. 22. The revenues of the Agency consist of:
I - the proceeds from the collection of the health surveillance inspection fee, as provided in this Law;
II - compensation for services of any kind rendered to third parties;
III - the proceeds from the collection of fines resulting from inspection actions;
IV - the proceeds from the enforcement of its active debt;
V - the appropriations allocated in the General Budget of the Union, special credits, additional credits, and transfers and pass-throughs granted to it;
VI - the funds from agreements, accords, or contracts entered into with national and international entities and organizations;
VII - donations, bequests, subsidies, and other funds allocated to it;
VIII - the amounts obtained from the sale or lease of movable and immovable property it owns; and,
IX - the proceeds from the sale of goods, objects, and instruments used to commit an infraction, as well as of the assets of the offenders, seized as a result of the exercise of police power and incorporated into the assets of the Agency pursuant to a court decision.
X - the amounts earned from investments in the financial market of the revenues provided for in items I to IV and VI to IX of this article. (Added by Provisional Measure 2.190-34 of 2001)
Sole paragraph. The funds provided for in items I, II, and VII of this article shall be paid directly to the Agency, in the manner defined by the Executive Branch.
Art. 23. The Health Surveillance Inspection Fee is hereby established.
§ 1 The taxable event of the Health Surveillance Inspection Fee is the performance of the acts within the competence of the National Health Surveillance Agency listed in Annex II.
§ 2 The taxpayers of the fee referred to in the caput of this article are the individuals and legal entities that engage in the manufacture, distribution, and sale of products and in the provision of services mentioned in Art. 8 of this Law.
§ 3 The fee shall be due in accordance with the respective taxable event, amount, and deadline set out in the table that constitutes Annex II to this Law.
§ 4 The fee shall be paid within the periods set forth in the Agency's own regulation. (See Provisional Measure 2.134-31 of 2001)
§ 4 The fee shall be paid under the terms set forth in an act of ANVISA itself. (Wording provided by Provisional Measure 2.190-34 of 2001)
§ 5 The Agency may, at its discretion, delegate the collection and billing of the fee referred to in this article to the States, the Federal District, and the Municipalities, in cases where they are carrying out surveillance actions, subject to § 1 of Art. 7 of this Law.
§ 6 In view of the public health interest, laboratories established or controlled by the Government that produce medicines and inputs subject to Law 6.360 of September 23, 1976, are exempt from paying the Health Surveillance Inspection Fee. (Included by Provisional Measure 2.190-34 of 2001)
§ 7 The periodicities and amounts stipulated for initial acts in the manner provided in the Annex apply to renewals of registrations, authorizations, and certificates. (Included by Provisional Measure 2.190-34 of 2001)
§ 8 The provisions of § 7 apply to the provisions of §§ 1 to 8 of Art. 12 and the sole paragraph of Art. 50 of Law 6.360 of 1976, § 2 of Art. 3 of Decree-Law 986 of October 21, 1969, and § 3 of Art. 41 of this Law. (Included by Provisional Measure 2.190-34 of 2001)
§ 9 Family farmers, as defined in Law 11.326 of July 24, 2006, and identified by the PRONAF Eligibility Declaration (DAP), whether Individual or Legal Entity, as well as the Individual Microentrepreneur provided for in Art. 18-A of Complementary Law 123 of December 14, 2006, and the solidarity economy entrepreneur, are exempt from paying the Health Surveillance Inspection Fee. (Included by Law 13.001 of 2014)
§ 10. Company operating authorizations provided for in the subitems of items 3.1, 3.2, 5.1, and 7.1 of Annex II are exempt from renewal. (Included by Law 13.097 of 2015)
Art. 24. A Fee that is not paid within the periods set by regulation, as provided in the preceding article, shall be collected with the following additions:
I - default interest, in administrative or judicial proceedings, counted from the month following the due date, at the rate of 1% per month, calculated in accordance with the legislation applicable to federal taxes;
II - a late-payment penalty of 20%, reduced to 10% if payment is made by the last business day of the month following the due date;
III - charges of 20%, in lieu of an order requiring the debtor to pay attorney's fees, calculated on the total debt entered in the Active Debt Roll, which shall be reduced to 10% if payment is made before the enforcement action is filed.
§ 1 Default interest does not apply to the amount of the late-payment penalty.
§ 2 Debts relating to the Fee may be paid in installments, at the discretion of the National Health Surveillance Agency, in accordance with the criteria set forth in the tax legislation.
Art. 25. The Health Surveillance Inspection Fee shall be due as of January 1, 1999.
Art. 26. The Health Surveillance Inspection Fee shall be paid into a bank account linked to the Agency.
Section II — Active Debt
Art. 27. Amounts whose collection is assigned to the Agency by law and that are determined administratively, but not paid within the stipulated period, shall be entered in the Agency's own active debt roll and shall serve as an enforceable instrument for judicial collection, as provided by Law.
Art. 28. The Agency's Attorney's Office shall bring the tax enforcement action for the active debt.
CHAPTER VI — Final and Transitional Provisions
Art. 29. In the first term of management of the Autarchy, in order to implement the transition to the system of non-coinciding terms:
I - three directors of the Agency shall be appointed by the President of the Republic, upon nomination by the Minister of State for Health;
II - two directors shall be appointed as provided in the sole paragraph of Art. 10 of this Law.
Sole paragraph. Of the three directors referred to in item I of this article, two shall be appointed for a term of four years and one for two years.
Art. 30. Once the National Health Surveillance Agency is constituted, with the publication of its Internal Rules by the Collegiate Board, the Health Surveillance Secretariat shall be abolished.
Art. 30. Once the National Health Surveillance Agency is constituted, with the publication of its internal rules by the Collegiate Board, the Autarchy shall automatically be vested with the exercise of its powers, and the Health Surveillance Secretariat shall be abolished. (Wording provided by Provisional Measure 2.190-34 of 2001)
Art. 31. The Executive Branch is authorized to:
I - transfer to the Agency the technical and property assets, obligations, rights, and revenues of the Ministry of Health and its bodies that are necessary for the performance of its functions;
II - reallocate, transfer, or use the budget balances of the Ministry of Health to meet the expenses of structuring and maintaining the Agency, using as resources the budget appropriations allocated to core and administrative activities, in compliance with the same subprojects, subactivities, and expense groups provided for in the Budget Law in force.
Art. 32. The National Institute for Health Quality Control, together with its institutional powers, property assets, and budget appropriations, is transferred from the Oswaldo Cruz Foundation to the National Health Surveillance Agency. (Repealed by Provisional Measure 2.190-34 of 2001)
Sole paragraph. The Osvaldo Cruz Foundation shall provide all support necessary to maintain the activities of the National Institute for Health Quality Control until the Agency is organized. (Repealed by Provisional Measure 2.190-34 of 2001)
Art. 32-A. The National Health Surveillance Agency may, by entering into technical and scientific cooperation agreements, request the performance of technical and scientific work, including work of an economic and legal nature, giving preference to higher education and research institutions maintained by the government and to international organizations with which Brazil has technical cooperation agreements. Effective date (Included by Law 12.090 of 2009).
Art. 33. The Agency may hire specialists to perform work in the technical, scientific, economic, and legal areas, for limited projects or periods, in compliance with the legislation in force.
Art. 34. During the first three years after its installation, the Agency may requisition, with cost to the Agency, employees or contractors from bodies of entities of the direct, indirect, or foundation-based Federal Public Administration, regardless of the functions to be performed. (Repealed by Law 9.986 of 2000)
§ 1 During the first twenty-four months following the installation of the Agency, the requisitions referred to in the main clause of this article may not be refused when made to bodies and entities of the Federal Executive Branch, provided that they are approved by the Ministers of State for Health and for Budget and Management. (Repealed by Law 9.986 of 2000)
§ 2 Where a requisition results in a reduction in the pay of the requisitioned employee, the Agency is authorized to supplement it up to the limit of the pay for the permanent position received at the body of origin. (Repealed by Law 9.986 of 2000)
Art. 35. ANVS is prohibited from hiring personnel who have an employment or contractual relationship with entities subject to Health Surveillance action, as well as the owners or persons in charge of such entities, except for participation in work committees created for a specific purpose and a fixed duration that are not part of its organizational structure.
Art. 36. The activities relating to the implementation, monitoring, and evaluation of core projects and programs in the area of health surveillance, and to the regulation and standardization of products, substances, and services of interest to health, that are essential to the installation of the Agency, are considered temporary needs of exceptional public interest, within the meaning of Art. 37 of the Federal Constitution. (See Provisional Measure 155 of 2003) (Repealed by Law 10.871 of 2004)
§ 1 ANVS is authorized to make temporary hires to perform the activities referred to in the main clause of this article, for a period not exceeding thirty-six months from its installation. (Repealed by Law 10.871 of 2004)
§ 2 Temporary personnel may be hired on account of the professional's notable technical or scientific capacity, based on a review of the curriculum vitae. (Repealed by Law 10.871 of 2004)
§ 3 Temporary hires shall be made for a fixed term, subject to a maximum period of twelve months, and may be extended provided that their duration does not exceed the end date of the authorization referred to in § 1. (Repealed by Law 10.871 of 2004)
§ 4 The pay of temporarily hired personnel shall be based on amounts defined in a joint act of ANVS and the central body of the Federal Administration Civil Personnel System (SIPEC). (Repealed by Law 10.871 of 2004)
§ 5 The provisions of Arts. 5 and 6, the sole paragraph of Art. 7, and Arts. 8, 9, 10, 11, 12, and 16 of Law 8.745 of December 9, 1993, apply to personnel temporarily hired by ANVS. (Repealed by Law 10.871 of 2004)
Art. 37. The Agency's staff may include employees redistributed from bodies and entities of the Federal Executive Branch. (Repealed by Law 9.986 of 2000)
Art. 38. For a period not exceeding five years, the inspection of products, services, producers, distributors, and merchants within the National Health Surveillance System may be carried out by an employee who has been requisitioned or who belongs to the staff of ANVS, upon designation by the Board, as provided by regulation.
Art. 39. Holders of permanent higher-level positions in the Science and Technology Research, Technological Development, and Science and Technology Management, Planning, and Infrastructure careers, created by Law 8.691 of July 28, 1993, who are engaged in activities inherent to their respective duties at the Agency, are entitled to the Science and Technology Activity Performance Bonus - GDCT, created by Law 9.638 of May 20, 1998. (Repealed by Provisional Measure 2.190-34 of 2001)
§ 1 The bonus referred to in the main clause shall also be due to holders of permanent intermediate-level positions in the Technological Development career who are engaged in activities inherent to their duties at the Agency. (Repealed by Provisional Measure 2.190-34 of 2001)
§ 2 The Science and Technology Activity Performance Bonus - GDCT, for holders of permanent intermediate-level positions in the Science and Technology Management, Planning, and Infrastructure career, created by Law 9.647 of May 26, 1998, shall be due to those employees who are engaged in activities inherent to the duties of their respective positions at the Agency. (Repealed by Provisional Measure 2.190-34 of 2001)
§ 3 For purposes of receiving the bonuses referred to in this article, the other criteria and rules established in the legislation in force shall be observed. (Repealed by Provisional Measure 2.190-34 of 2001)
§ 4 The provisions of this article apply only to employees of the Osvaldo Cruz Foundation assigned to the National Institute for Health Quality Control on December 31, 1998, who are redistributed to the Agency. (Repealed by Provisional Measure 2.190-34 of 2001)
Art. 40. The Office of the Attorney General of the Union and the Ministry of Health, through its Legal Counsel Office, by means of a joint committee, shall, within one hundred and eighty days, survey the pending lawsuits involving matters whose jurisdiction has been transferred to the Agency, which shall substitute for the Union in the respective proceedings.
§ 1º The substitution referred to in the caput, in those judicial proceedings, shall be requested by a petition signed by the Office of the Attorney General of the Union and addressed to the competent Court or Tribunal, requesting that the Agency's Attorney's Office be summoned to take over the case.
§ 2º Until the substitution is carried out as provided in the preceding paragraph, the Office of the Attorney General of the Union shall remain in the case and shall perform all necessary procedural acts.
Art. 41. The registration of the products addressed in Law 6.360 of 1976 and in Decree-Law 986 of October 21, 1969 may be regulated by the Ministry of Health and by the Agency, with a view to reducing bureaucracy and speeding up procedures, provided that this does not entail risks to the health of the population or to the ability to oversee production and circulation activities.
Sole paragraph. The Agency may grant operating authorization to companies, and registration to products, that apply only to production plants and to goods intended for foreign markets, provided that this does not entail risks to public health.
§ 1o The Agency may grant operating authorization to companies, and registration to products, that apply only to production plants and to goods intended for foreign markets, provided that they do not entail risks to public health. (Renumbered from the sole paragraph by Provisional Measure 2.190-34 of 2001)
§ 2o The regulation referred to in the caput of this article also covers exemption from registration. (Included by Provisional Measure 2.190-34 of 2001)
§ 3o Companies subject to Decree-Law 986 of 1969 are also required to comply with art. 2o of Law 6.360 of 1976, with regard to operating authorization by the Ministry of Health and licensing by the sanitary authorities of the Federative Units in which they are located. (See Provisional Measure 1.814-4 of 1999) (Included by Provisional Measure 2.190-34 of 2001)
Art. 41-A. The registration of medicines under an exclusively generic name shall take priority over the registration of other medicines, as provided in an act of the Collegiate Board of the National Health Surveillance Agency. (Included by Provisional Measure 2.190-34 of 2001)
Art. 41-B. When the sale of products subject to sanitary surveillance that are unfit for consumption is proven, the responsible company shall be required to run advertising containing a warning to the population, within the time and under the conditions indicated by the sanitary authority, and shall be subject to payment of a fee corresponding to the review and prior consent of the informational content by the National Health Surveillance Agency. (Included by Provisional Measure 2.190-34 of 2001)
Art. 42. Art. 57 of Decree-Law 986 of October 21, 1969 shall read as follows:
"Art. 57. The importation of foods, food additives, and substances intended for use in the manufacture of articles, utensils, and equipment intended to come into contact with foods is subject to the provisions of this Decree-Law and its Regulations, and the control analysis shall be carried out by sampling, at the discretion of the sanitary authority, at the time of unloading in the country." (NR)
Art. 43. The Agency may seize goods, equipment, products, and utensils used to commit a crime against public health and may arrange for their judicial sale, observing, where applicable, the provisions of art. 34 of Law 6.368 of October 21, 1976, and may also request in court the freezing of bank accounts held by the company and by its owners and officers who are responsible for committing those offenses.
Art. 44. Arts. 20 and 21 of Law 6.360 of September 23, 1976 shall read as follows:
"Art. 20........................................................................"
"Sole paragraph. A medicine whose composition does not include a substance recognized as beneficial from a clinical or therapeutic standpoint may not be registered." (NR)
"Art. 21. The right to register medicines similar to others already registered is guaranteed, provided that they meet the requirements established in this Law." (NR)
"§ 1º Similar medicines to be manufactured in the Country are deemed registered after one hundred and twenty days have elapsed from the submission of the respective application, if it has not been denied by then.
§ 2º The counting of the period for registration shall be suspended until the interested company satisfies a requirement of the sanitary authority, and such period may not exceed one hundred and eighty days.
§ 3º A registration granted under the conditions of the preceding paragraphs shall lose its validity, without need of notice or summons, if the product is not marketed within one year after the date it was granted, extendable by six more months, at the discretion of the sanitary authority, upon written justification submitted at the initiative of the interested company.
§ 4º The application for a new registration of the product may be filed two years after the occurrence of the fact that caused the loss of validity of the previously granted registration, unless that fact is not attributable to the interested company.
§ 5º The provisions of this article apply to products registered and manufactured in a State Party that is a member of the Southern Common Market - MERCOSUL, for purposes of their marketing in the Country, if they correspond to a domestic similar already registered."
Art. 45. This Law enters into force on the date of its publication.
Art. 46. Art. 58 of Decree-Law 986 of October 21, 1969 is repealed.
National Congress, January 26, 1999; 178th year of Independence and 111th of the Republic.
ANTONIO CARLOS MAGALHÃES President
This text does not replace the text published in the DOU of 27.1.1999
ANNEX I (See Provisional Measure 1.912-7 of 1999) (See Provisional Measure 2.134-28 of 2001) (Repealed by Provisional Measure 2.190-34 of 2001)
TABLE OF COMMISSIONED POSITIONS AND
COMMISSIONED SANITARY SURVEILLANCE FUNCTIONS
UNIT
POSITIONS/
FUNCTIONS
No.
DESIGNATION
POSITION/FUNCTION
NE/
DAS/
FG
BOARD OF DIRECTORS
5
NE
5
102.5
3
102.1
1
101.4
1
101.5
1
101.4
1
101.4
1
101.4
17
101.5
38
101.4
TABLE OF COMMISSIONED SANITARY SURVEILLANCE FUNCTIONS OF THE NATIONAL HEALTH SURVEILLANCE AGENCY
CODE/FCVS
QTY.
AMOUNT
FCVS-V
42
1.170,00
FCVS-IV
58
855,00
FCVS-III
47
515,00
FCVS-II
58
454,00
FCVS-I
69
402,00
TOTAL
274
177.005,00
ANNEX II SANITARY SURVEILLANCE INSPECTION FEE
Taxable Events
Amounts in R$
Renewal Periods
1. Operating authorization of a company, for each type of activity
40.000
annual
20.000
annual
1.3. Distributors of medicines, drugstores, and pharmacies
15.000
annual
10.000
annual
2. Amendment or addition to the authorization (type of activity, registration data,
6.600
indefinite
corporate merger or incorporation)
3. Replacement of legal representative or technical manager, or cancellation of authorization
Exempt
indefinite
4. Certification of good manufacturing and control practices for each establishment or manufacturing unit, type of activity, and production/marketing line
30.000
annual
12.000
annual
4.000
annual
37.000
annual
3.700
three years
11.700
three years
5.3.1. Equipment, Apparatus, and Instruments
65.000
three years
5.3.2. Others (diagnostic kits and blood bags)
16.300
three years
80.000
five years
35.000
five years
10.600
five years
10.000
five years
100.000
annual
1.800
indefinite
4.500
indefinite
6.3. Package insert text, instructions-for-use form, and labeling
2.200
indefinite
Exempt
indefinite
8.100
indefinite
2.200
indefinite
8. Certificate, attestation, toxicological classification, extension of use, marketing quota per company for a controlled product, and other declaratory acts
10.000
indefinite
9. Unarchiving of a case file and 2nd copy of a document
2.200
indefinite
10. Consent to the advertising notification of products, for airing for a maximum of 6 months
8.800
indefinite
11. Consent in an import or export process for clinical research
10.000
12. Consent for tax exemption and in an import or export process of products subject to Sanitary Surveillance.
Exempt
indefinite
13. Consent in an import and export process for the purpose of marketing a product subject to Sanitary Surveillance
100
indefinite
14. Collection and transport of samples for control analysis of imported products.
- within the municipality
- another municipality in the same State
- another State
150
300
600
Indefinite
15. Inspection to verify compliance with sanitary requirements
500
indefinite
16. Sanitary Control Activities at Ports, Airports, and Borders
16.1. Issuance of Deratting Certificate and Deratting Exemption Certificate for Vessels
1000
Indefinite
16.2. Issuance of Disembarkation Permit for Passengers and Crew of Vessels, Aircraft, and Land Vehicles in International Transit.
500
16.3. Issuance of Free Pratique Certificate
600
Indefinite
16.4. Issuance of Permit for Transfer of Human Remains - on Vessels, Aircraft, and Land Vehicles in Interstate and International Transit
150
indefinite
The amounts in the table, except for 16.1, 16.2, 16.3, and 16.4, are reduced by:
a) 30% in the case of medium-sized companies as defined by Law 9.531 of December 10, 1997;
b) 60% in the case of small companies as defined by Law 9.317 of December 5, 1996;
c) 90% in the case of microenterprises as defined by Law 9.317 of December 5, 1996.
Note: In the case of companies that are in the process of being set up, the fee shall be charged on the basis of a self-declaration, to be substantiated in the subsequent year, failing which the discounted amount shall become due.
ANNEX II (Wording provided by Provisional Measure 2.190-34 of 2001)
See Law 11.972 of 2009
(See Law 13.043 of 2014)
SANITARY SURVEILLANCE INSPECTION FEE
TAXABLE EVENTS
Period for
Renewal
1
1.1
Registration of foods, food additives, beverages, bottled waters, and recycled packaging
6.000
Five years
1.2
Amendment, inclusion, or exemption of registration of foods
1.800
---
1.3
Revalidation or renewal of registration of foods
6.000
Five years
1.4
Good Manufacturing Practices Certification for each establishment or manufacturing unit, per food production line
1.4.1
In the Country and MERCOSUL
1.4.1.1
Good Manufacturing and Control Practices Certification for each establishment or manufacturing unit, per type of activity and production or marketing line for food industries
15.000
Annual
1.4.2
Other countries
37.000
Annual
2
2.1
Registration of cosmetics
2.500
Five years
2.2
Amendment, inclusion, or exemption of registration of cosmetics
1.800
---
2.3
Revalidation or renewal of registration of cosmetics
2.500
Five years
2.4
Good Manufacturing Practices Certification for each establishment or manufacturing unit, per cosmetics production line
2.4.1
In the Country and MERCOSUL
2.4.1.1
Good Manufacturing Practices Certification for each establishment or manufacturing unit, per production line of cosmetics, hygiene products, and perfumes
15.000
Annual
2.4.2
Other countries
37.000
Annual
3.1
---
--- (See Law 13.043 of 2014)
3.1.1
Medicines industry
20.000
--- (See Law 13.043 of 2014)
3.1.2
Pharmaceutical inputs industry
20.000
--- (See Law 13.043 of 2014)
3.1.3
Distributor, importer, exporter, carrier, warehouse operator, packager, and repackager, and others provided for in specific legislation on medicines and pharmaceutical inputs
15.000
Annual (See Law 13.043 of 2014)
3.1.4
Fractioning of pharmaceutical inputs
15.000
Annual (See Law 13.043 of 2014)
3.1.5
Drugstores and pharmacies
500
Annual (See Law 13.043 of 2014)
3.1.6
Cosmetics, hygiene products, and perfumes industry
6.000
--- (See Law 13.043 of 2014)
3.1.7
Distributor, importer, exporter, carrier, warehouse operator, packager, and repackager, and others provided for in specific legislation on cosmetics, hygiene products, and perfumes
6.000
--- (See Law 13.043 of 2014)
3.1.8
6.000
--- (See Law 13.043 of 2014)
3.1.9
6.000
--- (See Law 13.043 of 2014)
3.2
Authorization and special authorization to operate a compounding pharmacy
5.000
Annual (See Law 13.043 of 2014)
4
4.1
Registration, revalidation, and renewal of registration of medicines
4.1.1
New product
80.000
Five years
4.1.2
Similar product
21.000
Five years
4.1.3
Generic product
6.000
Five years
4.1.4
New combination in the Country
21.000
---
4.1.5
Single drug approved in combination
21.000
---
4.1.6
New route of administration of the medicine in the Country
21.000
---
4.1.7
New concentration in the Country
21.000
---
4.1.8
New pharmaceutical form in the Country
21.000
---
4.1.9
Phytotherapeutic medicines
4.1.9.1
New product
6.000
Five years
4.1.9.2
Similar product
6.000
Five years
4.1.9.3
Traditional product
6.000
Five years
4.1.10
Homeopathic medicines
4.1.10.1
New product
6.000
Five years
4.1.10.2
Similar product
6.000
Five years
4.1.11
New packaging in the Country
1.800
---
4.2
Amendment, inclusion, or exemption of medicine registration
1.800
---
4.3
Good Manufacturing Practices Certification for each establishment or manufacturing unit, per medicine production line
4.3.1
In the Country and MERCOSUL
4.3.2
Good Manufacturing Practices Certification for medicines and pharmaceutical inputs
15.000
Annual
4.3.3
Other countries
37.000
Annual
4.3.4
Good Distribution and Storage Practices Certification for medicines and pharmaceutical inputs, per establishment
15.000
Annual
5.1
Operating Authorization
5.1.1
Operating authorization for companies that provide storage and distribution services for medicines, raw materials, and pharmaceutical inputs at bonded terminals for public use
15.000
Annual (See Law 13.043/2014)
5.1.2
Operating authorization for companies that provide storage and distribution services for substances and medicines under special control at bonded terminals for public use
15.000
Annual (See Law 13.043/2014)
5.1.3
Operating authorization for companies that provide storage and distribution services for cosmetics, hygiene products or perfumes, and raw materials at bonded terminals for public use
6.000
Annual (See Law 13.043/2014)
5.1.4
Operating authorization for companies that provide storage and distribution services for household sanitizing products and raw materials at bonded terminals for public use
6.000
Annual (See Law 13.043/2014)
5.1.5
Operating authorization for companies that provide storage and distribution services for medical-hospital materials and equipment and "in vitro" diagnostic products (related products) at bonded terminals for public use
6.000
Annual (See Law 13.043/2014)
5.1.6
Operating authorization for companies that provide storage and distribution services for food at bonded terminals for public use
6.000
Annual (See Law 13.043/2014)
5.1.7
Operating authorization for companies that provide alternative services for the supply of drinking water for human consumption aboard aircraft, vessels, and land vehicles that operate international collective passenger transport
6.000
Annual (See Law 13.043/2014)
5.1.8
Operating authorization for companies that provide disinsection or deratting services on vessels, land vehicles in transit through border stations and crossings, aircraft, port and airport cargo and traveler terminals, customs terminals for public use, and border stations and crossings
6.000
Annual (See Law 13.043/2014)
5.1.9
Operating authorization for companies that provide cleaning, disinfection, and decontamination services for surfaces of aircraft, land vehicles in transit through border stations and crossings, vessels, port and airport cargo and traveler terminals, customs terminals for public use, and border stations and crossings
6.000
Annual (See Law 13.043/2014)
5.1.10
Operating authorization for companies that provide cleaning and collection services for waste resulting from the treatment of wastewater and sewage at port and airport cargo and traveler terminals, customs terminals for public use, and border stations and crossings
6.000
Annual (See Law 13.043/2014)
5.1.11
Operating authorization for companies that provide emptying and treatment services for sanitary effluents of aircraft, vessels, and land vehicles in transit through border stations and crossings at airport terminals, port terminals, and border stations and crossings
6.000
Annual (See Law 13.043/2014)
5.1.12
Operating authorization for companies that provide segregation, collection, packaging, storage, transport, treatment, and final disposal services for solid waste resulting from aircraft, land vehicles in transit through border stations and crossings, vessels, port and airport cargo and traveler terminals, bonded terminals for public use, and border stations and crossings
6.000
Annual (See Law 13.043/2014)
5.1.13
Operating authorization for companies that operate the provision of services, in port areas, airport areas, and border stations and crossings, of laundry, medical care, hospitality, drugstores, pharmacies, and herbalists, trade in hospital materials and equipment, barbershops and hair salons, pedicurists and beauty institutes, and similar establishments
500
Annual (See Law 13.043/2014)
5.1.14
Operating authorization for companies appointed to manage, represent, or administer business on behalf of a shipping company, taking the measures necessary for the clearance of a vessel in port (shipping agency)
6.000
Annual (See Law 13.043/2014)
5.2
Approval in the import process for products subject to sanitary surveillance
5.2.1
Import approval, by legal entities, of goods, products, raw materials, and inputs subject to sanitary surveillance, for purposes of commercialization or industrialization
5.2.1.1
Import of up to ten items of goods, products, raw materials, or inputs
100
---
5.2.1.2
Import of eleven to twenty items of goods, products, raw materials, or inputs
200
---
5.2.1.3
Import of twenty-one to thirty items of goods, products, raw materials, or inputs
300
---
5.2.1.4
Import of thirty-one to fifty items of goods, products, raw materials, or inputs
1.000
---
5.2.1.5
Import of fifty-one to one hundred items of goods, products, raw materials, or inputs
2.000
---
5.3
Import approval, by individuals, of medical-hospital materials and equipment and "in vitro" diagnostic products subject to sanitary surveillance, for purposes of offering and trading in the provision of services to third parties
100
---
5.4
Import approval, by private hospitals and health establishments, of medical-hospital materials and equipment and "in vitro" diagnostic products subject to sanitary surveillance, for purposes of offering and trading in the provision of services to third parties
100
---
5.5
Import and export approval, by individuals, of products or raw materials subject to sanitary surveillance, for individual or personal use
EXEMPT
---
5.6
Import approval, by legal entities, of samples of products or raw materials subject to sanitary surveillance, for analyses and experiments, with a view to product registration
100
---
5.7
Import approval, by legal entities, of samples of products or raw materials subject to sanitary surveillance, for purposes of demonstration at fairs or public events
100
---
5.8
Import approval, by legal entities, of samples of products subject to sanitary surveillance, for purposes of demonstration to specialized professionals
100
---
5.9
Approval in the export process for products subject to sanitary surveillance
---
---
5.9.1
Export approval, by legal entities, of goods, products, raw materials, and inputs subject to sanitary surveillance, for purposes of commercialization or industrialization
EXEMPT
---
5.9.2
Export approval, by legal entities, of samples of goods, products, raw materials, or inputs subject to sanitary surveillance, for analyses and experiments, with a view to product registration
EXEMPT
---
5.9.3
Export approval, by legal entities, of samples of products or raw materials subject to sanitary surveillance, for purposes of demonstration at fairs or public events
EXEMPT
---
5.9.4
Export approval, by legal entities, of samples of products subject to sanitary surveillance, for purposes of demonstration to specialized professionals
EXEMPT
---
5.9.5
Export and import approval, by legal entities, of human biological samples, for purposes of conducting laboratory tests and experiments
5.9.5.1
Export and import of a maximum of twenty samples
100
---
5.9.5.2
Export and import of twenty-one to fifty samples
200
---
5.9.6
Export approval, by public research institutions, of human biological samples, for purposes of conducting laboratory tests and experiments
EXEMPT
---
5.9.7
Approval in a substitute import license related to import processes for products and raw materials subject to sanitary surveillance
50
---
5.10
Collection and transport of samples for laboratory analysis of imported products subject to control analysis
5.10.1
within the Municipality
150
---
5.10.2
another Municipality in the same State
300
---
5.10.3
another State
600
---
5.11
Inspection to verify compliance with sanitary requirements for the release from interdiction of imported products stored in an area outside the bonded terminal for public use
5.11.1
within the Municipality
150
---
5.11.2
another Municipality in the same State
300
---
5.11.3
another State
600
---
5.12
Semiannual inspection to verify compliance with sanitary requirements relating to the hygienic-sanitary conditions of platforms consisting of installations or structures, fixed or mobile, located in waters under national jurisdiction, intended for the direct or indirect activity of research and mining of mineral resources originating from the bed of inland waters or its subsoil, or from the sea, the continental shelf, or its subsoil
6.000
---
5.13
Approval for tax exemption in the import or export process for products subject to sanitary surveillance
EXEMPT
---
5.14
Port sanitary control activities
5.14.1
Issuance of the international deratting certificate and deratting exemption for vessels that engage in navigation in
5.14.1.1
Long-haul open sea, in international transit, with maritime, maritime-river, or maritime-lake movement, and that carry out cargo or passenger transport activities or services
1000
---
5.14.1.2
Long-haul open sea, in international transit, with maritime, maritime-river, or maritime-lake movement, and that carry out fishing activities
1000
---
5.14.1.3
Long-haul open sea, in international transit, with maritime, maritime-river, or maritime-lake movement, and that carry out sport and recreational activities for noncommercial purposes
EXEMPT
---
5.14.1.4
Inland waters, in international transit, with river movement and that carry out cargo or passenger transport activities or services
1000
---
5.14.1.5
Inland waters, in international transit, with river movement and that carry out fishing activities
1000
---
5.14.1.6
Inland waters, in international transit, with river movement and that carry out sport and recreational activities for noncommercial purposes
EXEMPT
---
5.14.2
Issuance of the national deratting certificates and deratting exemption for vessels that engage in navigation in
5.14.2.1
Open sea cabotage, in exclusively national transit, with maritime, maritime-river, or maritime-lake movement, and that carry out cargo or passenger transport activities or services
500
---
5.14.2.2
Open sea maritime support, in exclusively national transit and with maritime, maritime-river, or maritime-lake movement
500
---
5.14.2.3
Open sea that carry out another activity or service, in exclusively national transit and with maritime, maritime-river, or maritime-lake movement
500
---
5.14.2.4
Inland waters, in exclusively national transit, with maritime or maritime-lake movement and that carry out cargo or passenger transport activities or services
500
---
5.14.2.5
Inland, in exclusively national transit, with maritime-river, river, or river-lake movement, engaged in cargo or passenger transport activities or services
500
---
5.14.2.6
Inland, port support, in exclusively national transit, with maritime or maritime-lake movement.
500
---
5.14.2.7
Inland, port support, in exclusively national transit, with maritime-river, river, or river-lake movement
500
---
5.14.2.8
Inland, engaged in other activity or service, in exclusively national transit, with maritime or maritime-lake movement
500
---
5.14.2.9
Inland, engaged in other activity or service, in exclusively national transit, with maritime-river, river, or river-lake movement.
500
---
5.14.2.10
Open sea or inland, engaged in fishing activity, departing from and entering distinct ports in the national territory
500
---
5.14.2.11
Open sea or inland, engaged in fishing activity, departing from and returning to the same port in the national territory, with no intermediate stops
EXEMPT
---
5.14.2.12
Inland, engaged in sport and recreation activities for noncommercial purposes, in municipal, intermunicipal, or interstate transit, with maritime-river, river, or river-lake movement
EXEMPT
---
5.14.2.13
Inland, engaged in sport and recreation activities for noncommercial purposes, in municipal, intermunicipal, or interstate transit, with maritime or maritime-lake movement
EXEMPT
---
5.14.3
Issuance of disembarkation permit for passengers and crew of vessels, aircraft, or land vehicles in international transit
500
---
5.14.4
Issuance of the free pratique certificate for vessels that navigate in
5.14.4.1
Open sea, long-haul, in international transit, with maritime, maritime-river, or maritime-lake movement, engaged in cargo or passenger transport activities or services.
600
---
5.14.4.2
Open sea, long-haul, in international transit, with maritime, maritime-river, or maritime-lake movement, engaged in fishing activities
600
---
5.14.4.3
Open sea, long-haul, in international transit, with maritime, maritime-river, or maritime-lake movement, engaged in sport and recreation activities for noncommercial purposes.
EXEMPT
---
5.14.4.4
Open sea, long-haul, in international transit, with maritime, maritime-river, or maritime-lake movement, engaged in sport and recreation activities for commercial purposes
600
---
5.14.4.5
Inland, in international transit, with river movement, engaged in sport and recreation activities for noncommercial purposes
EXEMPT
---
5.14.4.6
Inland, in international transit, with river movement, engaged in sport and recreation activities for commercial purposes
600
---
5.14.4.7
Inland, in international transit, with river movement, engaged in fishing activities
600
---
5.14.4.8
Open sea, cabotage, in exclusively national transit, with maritime, maritime-river, or maritime-lake movement, engaged in cargo or passenger transport activities or services
600
---
5.14.4.9
Open sea, maritime support, in exclusively national transit, with maritime, maritime-river, or maritime-lake movement
600
---
5.14.4.10
Open sea, engaged in other activity or service, in exclusively national transit, with maritime, maritime-river, or maritime-lake movement
600
---
5.14.4.11
Inland, in exclusively national transit, with maritime or maritime-lake movement, engaged in cargo or passenger transport activities or services
600
---
5.14.4.12
Inland, in exclusively national transit, with maritime-river, river, or river-lake movement, engaged in cargo or passenger transport activities or services
600
---
5.14.4.13
Inland, port support, in exclusively national transit, with maritime or maritime-lake movement
600
---
5.14.4.14
Inland, port support, in exclusively national transit, with maritime-river, river, or river-lake movement
600
---
5.14.4.15
Inland, engaged in other activity or service, in exclusively national transit, with maritime or maritime-lake movement
600
---
5.14.4.16
Inland, engaged in other activity or service, in exclusively national transit, with maritime-river, river, or river-lake movement
600
---
5.14.4.17
Open sea or inland, engaged in fishing activity, departing from and entering distinct ports in the national territory
600
---
5.14.4.18
Open sea or inland, engaged in fishing activity, departing from and returning to the same port in the national territory, with no intermediate stops
EXEMPT
---
5.14.4.19
Inland, engaged in sport and recreation activities for noncommercial purposes, in municipal, intermunicipal, or interstate transit, with maritime or maritime-lake movement
EXEMPT
---
5.14.4.20
Inland, engaged in sport and recreation activities for noncommercial purposes, in municipal, intermunicipal, or interstate transit, with maritime-lake, maritime-river, river, or river-lake movement
EXEMPT
---
5.14.4.21
Any vessel of the Brazilian Navy, or under its invitation, used for noncommercial purposes
EXEMPT
---
6
6.1
Registration of sanitizing products
6.1.1
Risk Grade II Product
8.000
Five years
6.2
Amendment, inclusion, or exemption of registration of sanitizing products
1.800
---
6.3
Revalidation or renewal of registration of sanitizing products
6.3.1
Risk Grade II Product
8.000
Five years
6.4
Good Manufacturing Practices Certification for each establishment or manufacturing unit, per sanitizing products production line
6.4.1
In the Country and MERCOSUL
6.4.1.1
Good Manufacturing Practices Certification per establishment or manufacturing unit, per production line, for household sanitizing products industries
15.000
Annual
6.4.2
Other countries
37.000
Annual
7
7.1
Operating authorization and renewal for companies, per establishment or manufacturing unit, for each type of activity
---
--- (See Law 13.043 of 2014)
7.1.1
Per manufacturing establishment of one or more health products lines (equipment, materials, and "in vitro" diagnostic products)
10.000
--- (See Law 13.043 of 2014)
7.1.2
Distributor, importer, exporter, carrier, warehouser, packager, repackager, and others provided for in the specific legislation on health products
8.000
--- (See Law 13.043 of 2014)
7.1.3
Per retail establishment of health products
5.000
--- (See Law 13.043 of 2014)
7.2
Good Manufacturing Practices Certification for health products, for each establishment or manufacturing unit, per production line
---
7.2.1
In the Country and MERCOSUL
---
---
7.2.1.1
Good Manufacturing Practices Certification for health products
15.000
Annual
7.2.2
Other countries
37.000
Annual
7.3
Good Distribution and Storage Practices Certification for health products, per establishment
15.000
Annual See Law 11.972 of 2009
7.4
Modification or addition to the certification by inclusion of a new type of product line (equipment, materials, and "in vitro" diagnostic products)
5.000
---
7.5
Registration, revalidation, or renewal of registration of health products
7.5.1
Large-size equipment for diagnosis or therapy, such as nuclear medicine, computed tomography, magnetic resonance imaging, and cineangiocoronariography.
20.000
Five years
7.5.2
Other medium- and small-size equipment for diagnosis or therapy, articles, materials, "in vitro" diagnostic products, and other health products
8.000
Five years
7.5.3
Family of large-size equipment for diagnosis or therapy
28.000
Five years
7.5.4
Family of medium- and small-size equipment for diagnosis or therapy, articles, materials, "in vitro" diagnostic reagents, and other health products
12.000
Five years
7.6
Amendment, inclusion, or exemption in the registration of health products
1.800
---
7.7
Issuance of export certificate
EXEMPT
---
8
8.1
Toxicological assessment for product registration purposes
8.1.1
Technical product of an active ingredient not registered in the Country
1.800
---
8.1.2
Technical product of an active ingredient already registered in the Country
1.800
---
8.1.3
Formulated product
1.800
---
8.2
Toxicological assessment for registration of a component
1.800
---
8.3
Toxicological assessment for Temporary Special Registration purposes
1.800
---
8.4
Toxicological reclassification
1.800
---
8.5
Reassessment of product registration, pursuant to Decree 991/93
1.800
---
8.6
Toxicological assessment for crop inclusion purposes
1.800
---
8.7
Dose change
8.7.1
Dose change, upward, in application
1.800
---
8.8
Dose change, downward, in application
EXEMPT
---
9
9.1
Registration, revalidation, or renewal of registration of smoking products Registration, revalidation, or renewal of registration of smoking products, except for products intended exclusively for export. (Wording provided by Law 12.546 of 2011)
100.000
Annual
10
Consent to run advertising containing a warning to the public, within the time limit and under the conditions indicated by the health authority
10.000
---
11
Consent in a clinical research proceeding
10.000
---
12
Amendment or addition to the operating authorization
4.000
---
13
Replacement of legal representative or technical manager, or cancellation of authorization
EXEMPT
---
14
Certificate, attestation, and other declaratory acts
1.800
---
15
Unarchiving of a case file and duplicate copy of a document
1.800
Notes:
1. The amounts in the Table are reduced by:
a) fifteen percent, in the case of companies with annual revenue equal to or less than R$ 50.000.000,00 (fifty million reais) and greater than R$ 20.000.000,00 (twenty million reais);
b) thirty percent, in the case of companies with annual revenue equal to or less than R$ 20.000.000,00 (twenty million reais) and greater than R$ 6.000.000,00 (six million reais);
c) sixty percent, in the case of companies with annual revenue equal to or less than R$ 6.000.000,00 (six million reais);
d) ninety percent, in the case of small businesses;
e) ninety-five percent, in the case of microenterprises, except for items 3.1, whose amounts, in the case of a microenterprise, are reduced by ninety percent.
2. In items 3.1.1, 3.1.2, 3.1.6, 3.1.8, and 7.1.1, the manufacturing process includes the activities necessary to obtain the products mentioned in those items.
3. In items 3.1.3, 3.1.7, 3.1.9, and 7.1.2, the distribution of drugs, cosmetics, hygiene products, perfume, and household sanitizing products includes storage and dispatch activities.
4. For small businesses and microenterprises, the fee for granting the Good Manufacturing and Control Practices Certification shall be charged for each establishment or manufacturing unit.
5. Until December 31, 2001, microenterprises shall be exempt from the fee for granting the Good Manufacturing and Control Practices Certificate, Registration or Renewal of Registration of Products or Product Groups, as well as from the fees relating to the cases provided for in items 5.2.1 and 5.10.1. This exemption may be extended, until December 31, 2003, by decision of the Collegiate Board of ANVISA.
6. For purposes of Registration or Renewal of Registration, a drug that contains a new molecule and has patent protection shall be considered new.
7. The fee for Registration or Renewal of Registration of drugs or groups of drugs that are herbal, homeopathic, Large-Volume Parenteral Solutions, and Small-Volume Parenteral Solutions shall be that of item 4.1.3. Generics.
8. The amounts in the Table for Renewal of Registration of a Product or Product Group shall be reduced by ten percent upon renewal.
9. Classification as a small business or microenterprise, for the purposes provided for in item 1, shall be in accordance with Law 9.841 of October 5, 1999.
10. Payment of the fee is waived for issuance of certificates, attestations, and other declaratory acts, unarchiving of a case file, and duplicate copy of a document, when the activity is geared toward export.
11. Payment of the fee is exempt for the addition or alteration of a registration relating to package insert text, instructions-for-use form, and labeling, a change of telephone number, CGC/CNPJ number, or other legal information, as provided by act of the Collegiate Board of ANVISA.
12. The reduction amounts provided for in item 1 do not apply to items 3.1.5 and 5.1.13 of the Table, or to companies located in countries other than MERCOSUL members.
13. For companies engaged in express shipment (courier) activities that fall under letters "a", "b", and "c" of item 1 of the Notes, the single import clearance fee for the goods addressed in items 5.3, 5.4, 5.6, 5.7, and 5.8 of this Annex applies, regardless of revenue, in the amount of R$ 40,00.
14. For companies engaged in express shipment (courier) activities that fall under letters "a", "b", and "c" of item 1 of the Notes, the export clearance fee for the goods addressed in items 5.9.5.1 and 5.9.5.2 of this Annex applies, regardless of revenue, in the following amounts:
a) R$ 40,00, for a maximum of 20 samples per shipment to a consignee, verified by item, upon checking of the bill of lading by the health authority;
b) R$ 80,00, for 21 to 50 samples per shipment to a consignee, verified by item, upon checking of the bill of lading by the health authority.
15. The Collegiate Board of ANVISA shall adapt the provisions of item 5.14 and its discounts to the size of vessels by net tonnage and class, types of navigation, navigable waterways, and movements carried out.
16. For the purposes of the provisions of the preceding item, the following definitions apply:
16.1. Net tonnage - NT: an expression of the useful capacity of a vessel, determined in accordance with the provisions of these rules, as a function of the volume of enclosed spaces intended for cargo transport, the number of passengers carried, the location where the passengers will be carried, the draft/depth ratio, and the gross tonnage, net tonnage being further understood as a dimensionless size.
16.2. Vessel class: pleasure craft, fishing, passenger, cargo, mixed, and other.
16.3. Type of navigation:
16.3.1. Open Sea Navigation: carried out in maritime waters considered unsheltered, which may be:
16.3.1.1. Long-Haul: that carried out between Brazilian and foreign ports;
16.3.1.2. Cabotage: that carried out between ports or points of Brazilian territory using the sea route, or between the sea route and inland navigable waterways; and
16.3.1.3. Maritime Support: that carried out for logistical support to vessels and installations in national territorial waters and in the exclusive economic zone that engage in the research and extraction of minerals and hydrocarbons;
16.3.2. Inland Navigation: carried out in inland waterways, which are considered to be rivers, lakes, canals, lagoons, bays, coves, inlets, and maritime areas considered sheltered;
16.3.3. Port Support Navigation: carried out exclusively in ports and waterway terminals to serve vessels and port installations.
16.4. Navigable waterways: maritime, river, and lake.
16.5. Movements: municipal, intermunicipal, interstate, and international.
*